The epitranscriptome: At the crossroad of cancer prognosis.
作者信息
Di Fazio Pietro
机构信息
Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Germany.
出版信息
EBioMedicine. 2021 Feb;64:103231. doi: 10.1016/j.ebiom.2021.103231. Epub 2021 Jan 28.
Abstract
摘要
相似文献
1
The epitranscriptome: At the crossroad of cancer prognosis.表观转录组：癌症预后的交叉点
EBioMedicine. 2021 Feb;64:103231. doi: 10.1016/j.ebiom.2021.103231. Epub 2021 Jan 28.
2
Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.用于癌症分子诊断的DNA甲基化研究新兴技术。
Expert Rev Mol Diagn. 2015 May;15(5):647-64. doi: 10.1586/14737159.2015.1027194. Epub 2015 Mar 22.
3
Diagnostic and prognostic epigenetic biomarkers in cancer.癌症中的诊断和预后表观遗传生物标志物。
Epigenomics. 2015;7(6):1003-15. doi: 10.2217/epi.15.56. Epub 2015 Oct 7.
4
Tumor purity and differential methylation in cancer epigenomics.癌症表观基因组学中的肿瘤纯度与差异甲基化
Brief Funct Genomics. 2016 Nov;15(6):408-419. doi: 10.1093/bfgp/elw016. Epub 2016 May 19.
5
DNA methylation analysis in human cancer.人类癌症中的DNA甲基化分析。
Methods Mol Biol. 2013;980:131-56. doi: 10.1007/978-1-62703-287-2_7.
6
Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.1p36.13 号染色体的基因组和表观遗传学异常与恶性肿瘤的预后有关。
Chromosome Res. 2020 Dec;28(3-4):307-330. doi: 10.1007/s10577-020-09638-x. Epub 2020 Aug 20.
7
Epigenetics in cancer.癌症中的表观遗传学
N Engl J Med. 2008 Mar 13;358(11):1148-59. doi: 10.1056/NEJMra072067.
8
[Lung cancer and epigenetic modifications].[肺癌与表观遗传修饰]
Tuberk Toraks. 2016 Jun;64(2):163-70. doi: 10.5578/tt.10231.
9
Targeting the epigenome for treatment of cancer.针对表观基因组治疗癌症。
Oncogene. 2012 Aug 23;31(34):3827-44. doi: 10.1038/onc.2011.552. Epub 2011 Dec 5.
10
Multi-network approach to identify differentially methylated gene communities in cancer.多网络方法鉴定癌症中差异甲基化基因群落。
Gene. 2019 May 20;697:227-237. doi: 10.1016/j.gene.2019.02.007. Epub 2019 Feb 22.
引用本文的文献
1
FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer.FRA-1 作为乳腺癌 EMT 和转移的调节因子。
Int J Mol Sci. 2023 May 5;24(9):8307. doi: 10.3390/ijms24098307.
2
MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3.MFAP2 通过 m1A 甲基化上调，通过 CLK3 促进结直肠癌的侵袭性。
Cancer Med. 2023 Apr;12(7):8403-8414. doi: 10.1002/cam4.5561. Epub 2022 Dec 30.
Zotero 插件